03.31.25 -- Lethal Combat With Your CDMO

This webinar covers how preserving spatial molecular information enhances tissue analysis. It explores spatial-Omics platforms, AI models predicting treatment responses, and identifying patient subgroups. Topics include spatial-omics integration, AI-driven predictions, oncology applications, and improving molecular signatures for personalized medicine. Click here to learn more.

During a thorough analysis of the BIOSECURE Act's impact on risk management, compliance, and the future of global outsourcing in drug development and manufacturing, speakers conclude that the realities of 2024 indicate the answer is no — and explain why this is the correct assessment.

As the biotech industry continues to evolve, a growing gap in workforce readiness has emerged, driven by insufficient training for both new graduates and experienced professionals transitioning to advanced bioprocessing. Biotech Academy in Rome's Leonardo Sibilio addresses this challenge.

To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.

Discover how implementing a strategic approach to optimize the platform can establish a solid foundation for the efficient, reliable, and successful manufacturing of biopharmaceutical products.

Explore an approach to developing a sterilizing-grade filter for high-concentration biologics that enabled extensive filterability trials to be conducted without needing a large quantity of product.

See how our expertise in formulation and process development can ensure a seamless scale-up from laboratory to full-scale production of lyophilized injectable products.

Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Consider various dosing solutions and learn how to streamline your pediatric development journey.

Poland’s biomanufacturing scene presents many benefits to drug sponsors looking to partner globally, including cost-effectiveness, economic stability, and a culture that emphasizes a strong work ethic.

Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.

Late phase development requires a holistic development strategy driven by a well-defined target product profile. Here's an overview of the complex path to a successful product launch.

Streamline your ADC project with the Proveo alliance, offering seamless, end-to-end support across antibody production, bioconjugation, and aseptic fill.

Our comprehensive range of R&D services, cutting-edge technologies, and specialized expertise is tailored to meet customer needs at every stage of product development.

With advanced technologies and a team of scientific experts, SGS supports the development, validation, and commercialization of biologics, cell and gene therapies, and advanced treatments. 

Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.

Watch as leaders from FUJIFILM Diosynth Biotechnologie share inside details of the project that is giving patients access to medicine in a way the industry has never seen before.